Medro review

What it is

Medro Health Technologies, Inc. runs the website, product catalog and customer flow; it says plainly that it is not a medical provider or a pharmacy. Clinical care comes from Arora Health & Aesthetics, LLC, a medical group with an office in Seattle, led by Dr. Sean Arora, with Dr. Shannon Arora as chief medical officer. The partner pharmacy is The Pharmacy Hub in Miami, Florida, which Medro says is licensed to fill prescriptions in all 50 states. The company's copyright address is in San Francisco, and its terms are governed by Delaware law. Besides weight loss, Medro sells NAD⁺, sermorelin, glutathione and B12 injections, hair-loss treatments, sexual-health medications and estradiol. It's cash-pay only and isn't enrolled with Medicare or Medicaid. Users must be 18 or older. The site displays a LegitScript seal (ID 50716646). Its marketing has a few rough edges: one badge repeated across the site reads "Branded medication only" even though every GLP-1 it lists is compounded.

How it works

You start with a free online assessment that takes about three minutes, with no appointment needed. A licensed clinician from the partner group reviews your answers, usually within a day, and decides whether treatment is appropriate; a prescription is never guaranteed. If you're prescribed, your order ships from the partner pharmacy, typically within a day, and free expedited delivery usually takes one to two days. You manage your plan, messages and refills in your Medro account, and the care team handles questions about refills and next steps. Clinical questions go to the licensed partner rather than general support. Medro says it doesn't send sensitive health or intake data to advertising platforms, and it keeps public marketing tracking separate from care flows. If you're not eligible, you won't be prescribed, and Medro may suggest other options.

Pricing transparency

Compounded semaglutide is listed at $199 a month and compounded tirzepatide at $299, at the same price for every dose. An introductory code, applied automatically, takes $99 off your first treatment plan, so the first plan shows as $99 for semaglutide or $199 for tirzepatide. Microdose plans are listed from $119 for semaglutide and $139 for tirzepatide. The page notes that monthly, quarterly, half-yearly and yearly plans all renew automatically at regular pricing, and that the final price, which can vary with medication, dose, supply and eligibility, is shown before checkout if you're prescribed. It doesn't say which plan length the $199 and $299 figures belong to, so confirm the one-month price at checkout. There's no membership fee, and shipping is free. You're charged for your first month when you complete the intake. A medical disqualification gets you a full refund. Otherwise, you can cancel at any time by email or portal chat, but the request must arrive at least 72 hours before your billing date or you'll be charged once more; service continues to the end of the cycle, and no refund is given on cancellation. Damaged or incorrect medication is replaced by the pharmacy.

Branded vs compounded

Compounded semaglutide and compounded tirzepatide by weekly injection, each with added glycine and vitamin B12, plus lower-dose microdose versions of both. Medro's disclaimers say compounded medications aren't approved by the FDA and haven't been reviewed for safety, effectiveness or quality, and that it doesn't claim they are the same as brand-name drugs. Adding glycine and B12 hasn't been shown in trials to improve weight loss. The 15% to 20% average weight loss the site cites comes from trials of brand-name GLP-1s, and its before-and-after stories are labeled illustrative. The site mentions brand-name options in general terms, but none is listed with a price. A search of the FDA warning-letter database under Medro, its domain and its clinical partner returned no letters to these companies.

Pros and watch-outs

The evidence behind what Medro prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• “Microdosing” GLP-1 drugs: a trend, not a protocol — what the evidence says

  Sub-therapeutic semaglutide and tirzepatide is spreading fast. The pharmacology is clear, the honest part is clearer: efficacy is dose-related, and no trial has tested intentional microdosing.

How Medro compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Direct Meds

  Straightforward compounded GLP-1 without an insurance requirement

  See Direct Meds →
• Strut Health

  A general telehealth that covers GLP-1 alongside other everyday care

  See Strut Health →
• EOS Health

  Buyers who want a flat compounded price at any dose, from a company that names its clinical group and pharmacies

  See EOS Health →

More GLP-1 telehealth reviews: He & She MD · Superior Remedies · Try Ageless · Novi · Yucca Health · Sesame